Cargando…
Upregulation of YKL-40 Promotes Metastatic Phenotype and Correlates with Poor Prognosis and Therapy Response in Patients with Colorectal Cancer
YKL-40 is a heparin- and chitin-binding glycoprotein that belongs to the family of glycosyl hydrolases but lacks enzymatic properties. It affects different (patho)physiological processes, including cancer. In different tumors, YKL-40 gene overexpression has been linked to higher cell proliferation,...
Autores principales: | De Robertis, Mariangela, Greco, Maria Raffaella, Cardone, Rosa Angela, Mazza, Tommaso, Marzano, Flaviana, Mehterov, Nikolay, Kazakova, Maria, Belev, Nikolay, Tullo, Apollonia, Pesole, Graziano, Sarafian, Victoria, Signori, Emanuela |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9688424/ https://www.ncbi.nlm.nih.gov/pubmed/36428997 http://dx.doi.org/10.3390/cells11223568 |
Ejemplares similares
-
YKL-40 and the Cellular Metabolic Profile in Parkinson’s Disease
por: Gevezova, Maria, et al.
Publicado: (2023) -
Targeting Chemoresistant Tumors: Could TRIM Proteins-p53 Axis Be a Possible Answer?
por: Valletti, Alessio, et al.
Publicado: (2019) -
Emerging Roles of TRIM8 in Health and Disease
por: Marzano, Flaviana, et al.
Publicado: (2021) -
Alternative RNA Splicing—The Trojan Horse of Cancer Cells in Chemotherapy
por: Mehterov, Nikolay, et al.
Publicado: (2021) -
TRIM Proteins in Colorectal Cancer: TRIM8 as a Promising Therapeutic Target in Chemo Resistance
por: Marzano, Flaviana, et al.
Publicado: (2021)